ADIL News & Analysis

Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics for $32M

Adial Pharmaceuticals (ADIL) has acquired Azora Therapeutics for $32 million. This transaction is significant as it may broaden ADIL's portfolio and enhance its market presence. The deal could potentially impact ADIL's stock performance depending on the synergies and future revenues generated from Azora. Investors will be watching closely for any updates regarding the integration of the newly acquired assets.